** charts before earnings **
** charts after earnings **
- 3 days later
- 1 month later:
Kindred Healthcare beats by $0.11, reports revs in-line; guides FY17 EPS in-line, revs above consensus; Will discontinue quarterly cash dividend:
- Reports Q4 (Dec) earnings of $0.18 per share, excluding non-recurring items, $0.11 better than the Capital IQ Consensus of $0.07; revenues fell 2.0% year/year to $1.75 bln vs the $1.73 bln Capital IQ Consensus.
- Co issues guidance for FY17, sees EPS of $0.40-0.70, excluding non-recurring items, vs. $0.61 Capital IQ Consensus Estimate; sees FY17 revs of $7.1-7.3 bln vs. $6.89 bln Capital IQ Consensus Estimate.
- Core EBITDAR of $930 million, with a range of $910 million to $950 million
- Annual revenues of approximately $6.3 billion. Core EBITDAR of approximately $840 million. Core diluted EPS from continuing operations of approximately $0.80
- Change to dividend policy
- The Kindred Board of Directors declared a cash dividend of $0.12 per share on the Company's common stock payable on March 31, 2017 to shareholders of record as of the close of business on March 13, 2017. The Kindred Board of Directors has determined that trading levels of the Company's common stock do not sufficiently reflect the value of the Company's quarterly cash dividend. Following the payment of the quarterly cash dividend mentioned above, the Kindred Board of Directors has determined to discontinue the Company's quarterly cash dividend on its common stock and redirect the funds to repay debt and invest in growth.
No comments:
Post a Comment